Countermeasures to Circadian Misalignment (C2CM)

April 18, 2023 updated by: Colorado State University

Time-restricted Feeding to Mitigate Metabolic Impairments During Circadian Misalignment

Insufficient sleep and circadian misalignment are independent risk factors for the development of obesity and diabetes, yet few strategies exist to counter metabolic impairments when these behaviors are unavoidable.

This project will examine whether avoiding food intake during the biological night can mitigate the impact of circadian misalignment on metabolic homeostasis in adults during simulated night shift work. Findings from this study could identify a translatable strategy to minimize metabolic diseases in populations that include anyone working nonstandard hours such as police, paramedics, firefighters, military personnel, pilots, doctors and nurses, truck drivers, and individuals with sleep disorders.

Study Overview

Detailed Description

People who work evening, night or rotating shifts (i.e. "nonstandard" work hours) represent one in five U.S. employees and are alarmingly 44% more likely to develop Type 2 diabetes (T2D) compared to people who work standard day shifts. Circadian misalignment is one mechanism suggested to increases the risk of obesity and diabetes in people who work non-standard hours, and is highly prevalent and often unavoidable in modern, 24-hour society (e.g. shift work, long work hours, jet lag, medical residency, emergency responders, military personnel, Daylight Savings Time changes, etc). Disruptions in sleep and circadian rhythms have been linked to insulin resistance, increased energy intake, weight gain, and increased total body, abdominal and intrahepatic fat content, yet there have been limited attempts at identifying strategies or countermeasures to prevent the impact of such disruption on T2D risk in a sizeable proportion of the population.

Therefore, the long-term goal is to identify and develop effective, behavioral countermeasures to combat the increased risk for metabolic diseases associated with sleep and circadian disruption when these behaviors are unavoidable. The overall objective for this project is to test the impact of time-restricted feeding to a 7h period in the day as a noninvasive countermeasure to the metabolic impairments associated with circadian misalignment. The central hypothesis is that time-restricted feeding to the daytime period will prevent metabolic impairments during circadian misalignment compared to a condition where energy is consumed throughout the day and night. The rationale for the proposed project is that defining a non-invasive, scalable and feasible countermeasure to circadian misalignment could mitigate the risk of obesity and T2D.

To test the overall hypothesis, a randomized crossover study will be used with a rigorous inpatient diet, activity and light-controlled protocol in healthy men and women. The impact of time restricted feeding during circadian misalignment on metabolic homeostasis will be determined.

Findings from this study represent a critical advancement in the fields of translational circadian and metabolic physiology by identifying and testing a countermeasure to circadian misalignment. Achievement of the proposed aims could lead to the development of new intervention strategies for chronic disease prevention and management. The knowledge to be gained offers the potential to support cost-effective programs that may inform healthcare approach to metabolic disease prevention in populations at risk for these diseases such as shift workers, individuals with sleep disorders and anyone who eats outside of daytime hours.

Study Type

Interventional

Enrollment (Anticipated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Colorado
      • Fort Collins, Colorado, United States, 80523

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. 18-35 old; men and women; equal numbers of women and men will be included.
  2. Body Mass Index (BMI) between 20.0 and 24.9 ("normal" weight).
  3. Physical activity history: inactive to habitual moderate physical activity level
  4. Sleep/wake history: habitual sleep duration between 7-9.25 hours.
  5. Altitude history: Potential subjects must have lived at Denver altitude or higher for at least 3 months prior to inpatient stay.

Exclusion Criteria:

  1. Any clinically significant medical, psychiatric, or sleep disorder
  2. Use of prescribed medications/supplements/illicit drugs within one month prior to study
  3. History of shift work in year prior to study, or travel more than one time zone in three weeks prior to study. [NOTE: Subjects can be studied at a later date.]
  4. Women with history of prior gynecological pathology, <1 year post-partum, breast-feeding and/or pregnant.
  5. Non-English speakers will be excluded, as we do not have access to a translator who could rely accurate information to the participant for the consent or throughout the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Circadian misalignment (Condition A)
Participants will eat meals during the biological nighttime while remaining awake to mimic overnight work shifts.
Healthy lean subjects will undergo circadian misalignment induced using a simulated night shift-work protocol in both conditions of the study. Each condition will last approximately 6 days.
Experimental: Circadian misalignment with time-restricted feeding (Condition B)
Participants will fast during the biological nighttime while remaining awake to mimic overnight work shifts.
Healthy lean subjects will undergo circadian misalignment induced using a simulated night shift-work protocol in both conditions of the study. Each condition will last approximately 6 days.
Each subject will participate in both conditions (CM and CM+TRF)--one in which food is allowed during the nighttime period and one in which food will be restricted to the daytime only. Food intake will be matched across conditions and designed to keep participants weight stable.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Insulin sensitivity-derived from glucose tolerance test
Time Frame: Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Muscle tissue lipids-assessed by lipidomic analyses
Time Frame: Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Change to be assessed at Day 3, Day 5, Day 31, Day 33.

Secondary Outcome Measures

Outcome Measure
Time Frame
24-hour circulating blood glucose levels-assessed by assay
Time Frame: Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
24-hour circulating blood insulin levels-assessed by assay
Time Frame: Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
24-hour circulating blood free fatty acid levels-assessed by assay
Time Frame: Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Change to be assessed at Day 3, Day 5, Day 31, Day 33.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive assessments-Karolinska Sleepiness Scale
Time Frame: Change to be assessed at Day 3, Day 5, Day 31, Day 33.
subjective sleepiness measurement 1-9, 1=Very Alert, 9=Very sleepy, great effort to keep awake, fighting sleep
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Cognitive assessments-Positive and Negative Affect Schedule
Time Frame: Change to be assessed at Day 3, Day 5, Day 31, Day 33.
subjective emotions & feelings, Scores range from 10-50 with higher scores represent higher levels of positive affect of 20 emotions & feelings items, and lower scores represent lower levels of negative affect of 20 emotions & feelings items.
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Cognitive assessments- Psychomotor Vigilance Task
Time Frame: Change to be assessed at Day 3, Day 5, Day 31, Day 33.
reaction time
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Cognitive assessments- Conjunction Visual Search Task
Time Frame: Change to be assessed at Day 3, Day 5, Day 31, Day 33.
reaction time & error rate
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Sleep staging-assessed by polysomnography
Time Frame: Change to be assessed at Day 2, Day 4, Day 30, Day 32.
Electrical activity across the scalp will be measured using polysomnography and sleep will be staged as Wake, Stage 1, Stage 2, Stage 3 and REM.
Change to be assessed at Day 2, Day 4, Day 30, Day 32.
Sleep quality assessments-assessed by Actiwatch
Time Frame: Change to be assessed at Day 2, Day 4, Day 30, Day 32.
movement and light sensor equipment
Change to be assessed at Day 2, Day 4, Day 30, Day 32.
Sleep quality assessments-assessed by Maintenance of Wakefulness Test
Time Frame: Change to be assessed at Day 2, Day 4, Day 30, Day 32.
onset of sleep latency
Change to be assessed at Day 2, Day 4, Day 30, Day 32.
Sleep quality assessments-assessed by Leeds Sleep Evaluation Questionnaire
Time Frame: Change to be assessed at Day 2, Day 4, Day 30, Day 32.
subjective feelings of last night's sleep compared to usual of (1) getting to sleep- (easier, harder), (quicker, slower), (more drowsy, less drowsy); (2) quality of sleep- (more restful, less restful), (few periods of wakefulness, more periods of wakefulness); (3) awakening pattern-(easier, more difficult), (took shorter, took longer); (4) balance and coordination- (less clumsy, more clumsy)
Change to be assessed at Day 2, Day 4, Day 30, Day 32.
Functional grip strength-measured by hand dynamometer
Time Frame: Change to be assessed at Day 2, Day 4, Day 30, Day 32.
average force
Change to be assessed at Day 2, Day 4, Day 30, Day 32.
Functional balance-assessed by multi-sensor recorder
Time Frame: Change to be assessed at Day 1, Day 3, Day 29, Day 31.
gyroscope, accelerometer, attitude
Change to be assessed at Day 1, Day 3, Day 29, Day 31.
Systolic and diastolic blood pressure
Time Frame: Change to be assessed at Day 2, Day 4, Day 30, Day 32.
automatic vitals machine
Change to be assessed at Day 2, Day 4, Day 30, Day 32.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 7, 2021

Primary Completion (Anticipated)

March 31, 2025

Study Completion (Anticipated)

June 30, 2025

Study Registration Dates

First Submitted

May 9, 2021

First Submitted That Met QC Criteria

July 7, 2021

First Posted (Actual)

July 19, 2021

Study Record Updates

Last Update Posted (Actual)

April 20, 2023

Last Update Submitted That Met QC Criteria

April 18, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insulin Sensitivity

Clinical Trials on Circadian Misalignment

3
Subscribe